Form 4: Alignment Healthcare Director Sells Shares Under 10b5-1 Plan

Alignment Healthcare Director Joseph S. Konowiecki sold 25,000 shares of common stock for $17 per share, executed under a pre-arranged 10b5-1 plan.

Summary

• Director Joseph S. Konowiecki of Alignment Healthcare, Inc. (ALHC) reported a sale of common stock.
• The transaction involved the disposition of 25,000 shares.
• The shares were sold at a price of $17 per share.
• The sale was executed on September 9, 2025.
• This transaction was conducted under a Rule 10b5-1 trading plan, which was adopted on March 5, 2025.
• Following the sale, Konowiecki beneficially owns 1,127,049 shares of Alignment Healthcare common stock.

Sentiment

Score: 4

Explanation: The sale of shares by a director, even under a pre-arranged plan, can be perceived as a slight negative signal, though the 10b5-1 plan mitigates immediate concerns about opportunistic selling.

Negatives

• Director Joseph S. Konowiecki sold 25,000 shares of common stock.
• The sale price was $17 per share.

Future Outlook

NA

Industry Context

NA

Corporate Governance

Stakeholder Impact

• Shareholders: May interpret the director's sale as a lack of confidence, potentially impacting stock price perception, although the 10b5-1 plan suggests a pre-scheduled, non-opportunistic sale.

Key Dates

Recommendation

The reported sale by a director, while notable, was conducted under a pre-arranged Rule 10b5-1 plan, indicating it was not an opportunistic trade based on new material non-public information. A single insider transaction typically does not warrant a change in investment thesis without broader fundamental shifts or a pattern of significant insider activity.

Keywords

Alignment Healthcare, ALHC, Insider Sale, Form 4, Joseph S. Konowiecki, Director, Stock Transaction, 10b5-1 Plan